Schedule 13G ownership disclosure
Vir Biotechnology Inc
Security class unavailable · CUSIP: 92764N102
Event date: 2020-04-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,555,556
- Percent of class
- 5.0600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000898432-20-000544
- Form type
- SC 13G
- Filer
- Alaska Permanent Fund Corp
- CIK
- CIK 1582681
- Filed
- May 07, 2020
- Reporting period
- Apr 14, 2020
- Description
- Schedule 13G beneficial ownership